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90Risk factors for readmission after lower extremity
procedures for peripheral artery disease
Todd R. Vogel, MD, MPH,a and Robin L. Kruse, PhD,b Columbia, Mo
Objective: As pressure to contain health care costs increases, there has been greater scrutiny of readmissions in the vascular
surgery population. The objective of this study was to evaluate postoperative readmissions after open and endovascular
lower extremity (LE) procedures for peripheral artery disease (PAD).
Methods: A retrospective cohort study was performed of elective adult inpatients with PAD and LE procedures which were
selected from the Health Facts database (Cerner Corporation, Kansas City, Mo) between October 2008 and December
2010 using International Classiﬁcation of Disease, 9th Clinical Modiﬁcation diagnosis codes (claudication, rest pain, and
ulceration/gangrene) and procedure codes for LE revascularization (endovascular and open). Multivariable logistic
regression and c2 were used to compare patients who received endovascular and open procedures. The Charlson
Comorbidity Index, comorbid diagnoses, and laboratory results were used to adjust for confounding. The main outcome
measure evaluated was readmission #30 days of discharge.
Results: Of 463,362 index admissions, 16,574 patients were identiﬁed with a diagnosis of PAD. Combining PAD with
elective LE procedures during the index admission, 777 underwent open and 681 underwent endovascular procedures.
Unadjusted readmission rates for open and endovascular procedures for claudication, rest pain, and ulceration/gangrene
were 10.2% vs 11.3% (P [ .69), 14.0% vs 18.2% (P [ .43), and 21.1% vs 19.5% (P [ .69), respectively. Readmission
increased by the severity of the diagnosis for open and endovascular procedures (P[ .0006). Men comprised 58% of the
cohort; readmission rates were not statistically different by sex (P [ .19). Race was not associated with procedure per-
formed (P [ .16), but nonwhite race was associated with more severe PAD (P < .0001). After adjusting for race, sex,
comorbidities, length of stay, and laboratory values outside of normal reference ranges, the association between an
endovascular procedure and readmission was not statistically signiﬁcant (odds ratio, 1.28; 95% conﬁdence interval, 0.94-
1.75).
Conclusions: Less invasive endovascular procedures were not associated with decreased readmission rates compared with
open surgery. The overall readmission rate for claudicant patients was 10.7%, which was unexpectedly high. Predictors of
readmission included male sex, longer hospital stays, hospital infection, elevated aspartate aminotransferase, and high
numbers of medications ordered and dispensed. Further examination exploring reasons for readmission are required to
decrease readmission rates in the vascular surgery population. (J Vasc Surg 2013;58:90-7.)Dramatic changes in health care delivery and rising
interest in cost containment have increased concern
regarding readmission and its cost to the health care
system. In the Medicare population, the readmission rate
after vascular surgical procedures is almost 24%, substan-
tially higher than the average rate of 15.6% for other
surgical procedures.1 At the same time there has been
a dramatic shift in the use of endovascular procedures for
the management of lower extremity (LE) occlusive
disease.2 Endovascular interventions are now performed
much more commonly than bypass surgery in the treat-
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://dx.doi.org/10.1016/j.jvs.2012.12.031of percutaneous transluminal angioplasty (PTA) for claudi-
cation has dramatically increased.2,3
Despite increased use of more minimally invasive
procedures, there is a paucity of information evaluating if
less invasive procedures are associated with decreased
morbidity and also speciﬁcally with decreased use in the
form of readmission. This analysis evaluated the readmis-
sion rates after LE interventions to speciﬁcally compare
rates between procedure type and to evaluate factors asso-
ciated with readmission, because identifying patients with
increased risk for readmission after vascular procedures
may lead to more effective, higher-quality care.
METHODS
We conducted a retrospective cohort study of 30-day
readmission after hospitalization in which a LE procedure
was performed for patients with PAD. We identiﬁed risk
factors for readmission and used these factors in a multivari-
able logistic regression to determine whether the type of LE
procedure (open or endovascular) was associated with read-
mission. The Health Sciences Institutional Review Board at
the University of Missouri exempted the study from review.
Data source. We used the Health Facts proprietary
database (Cerner Corporation, Kansas City, Mo), consist-
ing of electronic clinical records from hospitals and hospital
systems that use Cerner’s electronic health record.
Table I. International Classiﬁcation of Diseases, Ninth
Revision, Clinical Modiﬁcation (ICD-9-CM) codes used
to identify patients with peripheral artery disease (PAD)
and lower extremity proceduresa
ICD-9-CM codes Description
Diagnosis codes for PAD
440.20 Atherosclerosis of native arteries of the
extremities, unspeciﬁed
440.21 Atherosclerosis of native arteries of the
extremities with intermittent
claudication
440.22 Atherosclerosis of native arteries of the
extremities with rest pain
440.23 Atherosclerosis of native arteries of the
extremities with ulceration
440.24 Atherosclerosis of native arteries of the
extremities with gangrene
440.29 Other atherosclerosis of native arteries of
the extremities
440.4 Chronic total occlusion of artery of the
extremities
443.9 Unspeciﬁed peripheral vascular disease
785.4 Gangrene
Open lower extremity procedure codes
38.08 Incision of lower limb arteries
38.18 Endarterectomy of lower limb arteries
38.38 Resection of lower limb arteries with
anastomosis
38.48 Resection of lower limb arteries with
replacement
39.29 Other (peripheral) vascular shunt or bypass
39.56 Repair of blood vessel with tissue patch
graft
39.57 Repair of blood vessel with synthetic patch
graft
39.58 Repair of blood vessel with unspeciﬁed
type of patch graft
Endovascular lower extremity procedure codes
39.50 Angioplasty of other noncoronary vessel(s)
39.90 Insertion of nondrug-eluting peripheral
vessel stents(s)
aTo be included, a patient must have one or more diagnosis codes and one
or more procedure codes from the open or endovascular category.
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vidually determine what data elements to contribute,
potentially including billing and encounter data, medica-
tion ordering and dispensing, and diagnostic test results.
Cerner Corporation deidentiﬁes the data before inclusion
in Health Facts using statistical methods that are compliant
with the Health Insurance Portability and Accountability
Act. Data undergo rigorous validity checks before inclusion
in Health Facts.
Study population. We included elective inpatient
admissions that contained diagnosis and procedure data,
medication orders, and laboratory orders. We excluded
(1) patients aged <18 years at admission, (2) stays with
a primary or secondary diagnosis of pregnancy or complica-
tions of pregnancy, childbirth, and the puerperium (Inter-
national Classiﬁcation of Diseases, Ninth Revision, Clinical
Modiﬁcation [ICD-9-CM] diagnosis codes 630-679), or
primary or secondary obstetrical procedures (ICD-9-CM
procedure codes 72-75), and (3) stays where the
predominant care setting was a psychiatric or rehabilitation
unit (>90% of medication orders originated from
a psychiatric or rehabilitation unit).
A patient’s index admission was deﬁned as the ﬁrst
acute care hospital admission between October 1, 2008,
and August 31, 2010. From these admissions, we included
elective admissions during which an LE procedure was per-
formed and the patient had a diagnosis of PAD (Table I).
Except when a patient was admitted through the emer-
gency department, elective admissions were determined
by the admitting physician’s designation. We excluded
admissions during which endovascular and open proce-
dures were both performed. We identiﬁed readmissions
#30 days of discharge from the index admission, excluding
elective readmissions. Readmissions #24 hours of
discharge from the index admission were combined with
the index admission (most were #3 hours and were likely
coding errors).
Missing data. Missing laboratory data were common.
We assumed that if a particular laboratory test was not per-
formed that the care team believed there was no reason to
order the test. For all laboratory variables, patients who did
not receive the test had a lower readmission rate than those
who received the test. We therefore assumed results of
missing laboratory tests were within the normal reference
range. Similarly, we assumed “missing” procedures and
medications were not ordered or performed.
Statistical analysis. All analyses were computed using
SAS 9.3 software (SAS Institute, Cary, NC). The c2
statistic was used to determine the variables that were asso-
ciated with readmission in bivariable analyses. Odds ratios
(OR) and 95% conﬁdence intervals (CI) were calculated.
Multivariable logistic regression was used to compare
patients who received endovascular or open procedures.
During model development, we considered statistical
signiﬁcance and the size of the ORs. Variables that were
associated with readmission in bivariable analyses were
included as potential covariates in the logistic model if
the P value for their bivariable association was #.15.Because there were a large number of candidate variables,
regression models were ﬁrst developed for categories of
variables (eg, diagnoses, laboratory values). Variables
within categories with statistically signiﬁcant relationships
to readmission were then allowed to enter a stepwise
logistic model. We included PAD diagnosis, procedure
type, sex, African American ethnicity, and the Charlson
Comorbidity Index (CCI),4 allowing other variables to
enter depending on statistical signiﬁcance. The C statistic
(area under the receiver operating characteristic curve)
was used to assess model discrimination; that is, how well
the model distinguishes patients who were and were not
readmitted. The C statistic varies from 0.5 to 1, with 1 rep-
resenting perfect discrimination and 0.5 indicating that
results are no better than a coin ﬂip. The Hosmer-
Lemeshow goodness-of-ﬁt statistic was used to assess
model calibration, or how well the model performs across
the range of predicted readmission (nonsigniﬁcant values
Table II. Characteristics of participating hospitals
Characteristic
Hospitals (n ¼ 45) Patients (n ¼ 1458)
No. (%) No. (%)
Bed size category
<200 12 (26.7) 130 (8.9)
200-299 12 (26.7) 297 (20.4)
300-499 13 (28.9) 322 (22.1)
$500 8 (17.8) 709 (48.6)
Census region
Northeast 15 (33.3) 442 (30.3)
Midwest 11 (24.4) 383 (26.3)
South 16 (35.6) 590 (40.5)
West 3 (6.7) 43 (2.9)
Teaching status
Teaching 27 (60.0) 1035 (71.0)
Nonteaching 18 (40.0) 423 (29.0)
Fig. Flow chart of patients analyzed in the study. LE, Lower
extremity; PAD, peripheral arterial disease.
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equations to adjust the logistic regression model for clus-
tering of patients within hospitals.
RESULTS
Characteristics of the hospitals included in the data are
reported in Table II. All were in urban locations and most
were teaching hospitals. Most hospitals in the sample had
more than one patient in the study (range, 1-147).
Derivation of the study cohort is depicted in the Fig.
There were 777 open procedures and 681 endovascular
procedures (Table III). The overall readmission rate was
14.5%, with 13.9% of patients who received an open proce-
dure readmitted within #30 days compared with 15.3% of
patients who had endovascular procedures. Intermittent
claudication was present in 34.6% of patients, 15.8%
had rest pain, 13.7% had an ulcer, 11.3% had gangrene,
and 24.6% had PAD of unspeciﬁed severity. With the
exception of patients with rest pain, who mostly received
open procedures, the two procedure types were fairly
evenly distributed within diagnoses. The unadjusted OR
for readmission of patients who received open procedures
was 0.90 (95% CI, 0.67-1.20; P ¼ .46).
Of the total cohort, 58.2% were men. Patients were
a mean age of 68.0 years (95% CI, 67.4-68.6), and 46.4%
were aged $70 years. By race, 77.4% were white and
19.6% were African American. Table IV reports the associa-
tion of individual risk factors with 30-day readmission. With
the exception of African American ethnicity (OR, 1.56; 95%
CI, 1.11-2.19), demographic characteristics were not associ-
ated with readmission.No hospital characteristic was statisti-
cally signiﬁcantly related to readmission. Hospital exposure
in the year before admissionwas not associatedwith readmis-
sion, but a length of stay (LOS) of $7 days was (OR, 2.54;
95% CI, 1.68-3.85). Higher CCI scores were associated
with readmission, as were several diagnoses and laboratory
abnormalities. See Supplementary Tables I and II (online
only) for a detailed bivariable association of selected factors
with receipt of open or endovascular lower extremity
procedure.A subset analysis of patients with claudication showed
that 54 of the 505 patients with claudication were readmit-
ted. Analysis using the same procedures as for the entire
population was performed. As with the entire population,
African American patients (OR, 2.22; 95% CI, 1.08-
4.54) and those with a longer LOS (OR, 1.67; 95% CI,
1.08-2.60 per 5 days) were at higher risk of readmission.
In addition, being in a nonteaching hospital (OR, 1.97;
95% CI, 1.02-3.81), having chronic kidney disease
(OR, 3.0; 95% CI, 1.32-6.79), or a white blood cell
(WBC) count >15,000/mL (OR, 2.81; 95% CI, 1.15-
6.87) were all associated with readmission in this group.
Table V reports results from generalized estimating
equations. After controlling for PAD diagnosis, male
sex, African American ethnicity, LOS, CCI, elevated
aspartate aminotransferase, and high medication use, an
endovascular procedure was not associated with readmis-
sion (OR, 1.28; 95% CI, 0.96-1.73). Compared with
patients with claudication or PAD of unspeciﬁed severity,
more severe PAD diagnoses were also not statistically
signiﬁcant. When we analyzed aspartate aminotransferase
Table III. Procedure type and 30-day readmission by severity of peripheral arterial disease (PAD)
PAD severity
Procedure type, No. (%)a,b Readmitted, No. (%)c
Open Endovascular Open Endovascular Pd
Unspeciﬁed 149 (41.6) 209 (58.4) 18 (12.1) 31 (14.8) .45
Intermittent claudication 284 (56.2) 221 (43.8) 29 (10.2) 25 (11.3) .69
Rest pain 164 (71.3) 66 (28.7) 23 (14.0) 12 (18.2) .43
Ulcer 98 (49.0) 102 (51.0) 20 (20.4) 16 (15.7) .38
Gangrene 82 (49.7) 83 (50.3) 18 (22.0) 20 (24.1) .74
Total 777 (46.7) 681 (53.3) 108 (13.9) 104 (15.3)
aPercentage within categories of PAD severity.
bc2 test for the distribution of procedure type by diagnosis category.
cPercentage of patients within category of PAD severity who received that type of procedure.
dP <.0001. Comparison of readmission by procedure type within diagnosis categories, c2.
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explore the effects of missing values, results were essen-
tially unchanged.
DISCUSSION
We found a substantial overall readmission rate after
LE procedures of 14.5%, with 13.9% of patients who
received an open procedure readmitted within #30 days
compared with 15.3% of patients who had endovascular
procedures. After controlling for confounding in a multivar-
iable logistic regression model, endovascular procedures
were not associated with reduced readmission (OR, 1.28;
95% CI, 0.96-1.73; P ¼ .097).
The readmission rate increased with disease severity;
however, the 10.7% readmission rate for claudicant patients
was unexpectedly high. When further evaluations of patient
characteristics associated with readmission were analyzed,
LOS, comorbidities, and sepsis were statistically signiﬁcant
in unadjusted analyses. More granular laboratory data con-
tained within the data set demonstrated that liver failure
(aspartate aminotransferase >100 U/L), glomerular ﬁltra-
tion rate<40 mL/min/1.73 m2, serum albumin<3 g/dL,
and WBC count >15,000/mL were signiﬁcantly associated
with readmission after an LE procedure, although only
aspartate aminotransferase was statistically signiﬁcant in
the multivariable model.
With the changes occurring in health care delivery and
rising interest in cost containment, there is increased
concern regarding hospital readmission. Vascular surgery
patients account for a large portion of 30-day readmissions
in the Medicare population at almost 24%.1 There is
currently insufﬁcient information evaluating the readmis-
sion rates after LE procedures. Risk factors associated with
readmission remain poorly deﬁned, and further research
into creating future interventions will be needed to decrease
readmission rates.5 In this health care climate, there has also
been an increase in the use of endovascular procedures for
the management of LE PAD.6 Other researchers found
that endovascular interventions were more often performed
and that major LE amputation rates have fallen by >25%.3
Despite these advances in LE endovascular technology,
few have assessed its effect on readmission.Comorbidities have been traditionally associated with
unplanned readmission.7 Our analysis found that patients
with increased numbers of comorbidities, as deﬁned by the
CCI, weremore likely to be readmitted#30 days than those
with fewer comorbidities. Other authors have described the
effect of comorbidities and used them to create a validated
score to predict readmission #30 days.7 Coronary artery
bypass graft (CABG) surgery, which is a comparable patient
population, has also been studied, and numerous comorbid-
ities were associated with readmission after CABG.8
Further analysis of our LE procedure cohort demon-
strated that diabetic patients were 1.41 times as likely to
be readmitted. Jackson et al9 also found that diabetes was
associated with unplanned 30-day rehospitalization in
multivariable analysis and suggested that strategies designed
to reduce rehospitalization in diabetic patients should be
addressed. Using laboratory data, we also found that
end-stage renal disease was associated with readmission.
Serum creatinine $2 mg/dL and an estimated glomerular
ﬁltration rate <40 mL/min/1.73 m2 were signiﬁcantly
associated with readmission. Previous studies looking
at tibioperoneal interventions showed that among comor-
bidities, predictors of 30-day rehospitalization included
chronic renal failure.10 In contrast, Kassin et al11 evaluated
the association between comorbidities and readmission in
the general surgical population and did not ﬁnd that dia-
betes or chronic renal failure requiring dialysis was associ-
ated with readmission. Their study was performed in
a general surgery population and highlights the importance
of analysis looking at speciﬁc surgical populations to delin-
eate appropriate predictors of readmission by procedure.
Regarding other speciﬁc laboratory data, liver dysfunc-
tionwas signiﬁcantly associatedwith readmission.A total bili-
rubin >2 mg/dL was signiﬁcantly associated with
readmission, and these patients were 5.15 times as likely to
be readmitted. As well, patients with aspartate aminotrans-
ferase>100U/L were 2.89 times as likely to be readmitted.
Our analysis also evaluated cardiac factors and their associa-
tion with readmission after LE procedures. We did not ﬁnd
a signiﬁcant association with troponin I >0.2 mg/L, but
patients with a hemoglobin level <8 g/dL were 2.17 times
as likely to require readmission. Reasons for this ﬁnding
Table IV. Bivariable association of selected risk factors with 30-day readmission after hospital discharge for patients who
received a lower extremity procedure for peripheral artery disease (PAD) (n ¼ 1458)
Patient characteristics (No. missing) Patients, No.
Patients who were readmitted
No. (%) OR (95% CI) Pa
Demographics
Age, years (0)
18-49 78 12 (15.4) Reference
50-59 263 35 (13.3) 0.84 (0.42-1.72) .64
60-69 440 63 (14.3) 0.92 (0.47-1.80) .80
70-79 439 74 (16.9) 1.12 (0.57-2.17) .75
80-90b 238 28 (11.8) 0.73 (0.35-1.52) .40
Insurance (340)
Commercial, other 168 26 (15.5) Reference
Medicarec 844 128 (15.2) 0.98 (0.62-1.54) .92
Medicaid 56 5 (8.9) 0.54 (0.19-1.47) .22
Self-pay 50 4 (8.0) 0.48 (0.16-1.43) .18
Unknown 340 49 (14.4) 0.92 (0.55-1.54) .75
Marital status (271)
Married/life partner 614 100 (16.3) Reference
Divorced/separated 146 21 (14.4) 0.86 (0.52-1.44) .57
Single 187 26 (13.9) 0.83 (0.52-1.32) .43
Widowed 240 31 (12.9) 0.76 (0.49-1.18) .22
Unknown 271 34 (12.6) 0.74 (0.48-1.12) .15
Race/ethnicity (20)
African American 285 56 (19.6) 1.56 (1.11-2.19) .01
Caucasian 1129 153 (13.6) Reference
Other known/unknown 44 3 (6.8) 0.47 (0.14-1.53) .20
Sex (4)
Female 610 80 (13.1) Reference
Male 848 132 (15.6) 1.22 (0.91-1.65) .19
Hospital characteristics
Hospital bed size category (0)
<200 130 17 (13.1) Reference
200-299 297 44 (14.8) 1.16 (0.63-2.11) .64
300-499 322 40 (12.4) 0.94 (0.51-1.73) .85
$500 709 111 (15.7) 1.23 (0.71-2.14) .45
Teaching status (0)
Teaching 1035 157 (15.2) Reference .29
Nonteaching 423 55 (13.0) .84 (0.60-1.16)
Admission source (99)
Hospital, other facility 27 7 (25.9) 2.11 (0.88-5.06) .087
Skilled nursing facility, nursing home 10 3 (30.0) 2.59 (0.66-10.1) .16
Other 1322 188 (14.2) Reference
Unknown 99 14 (14.1) 0.99 (0.55-1.79) .98
Health care utilization
Hospital exposure prior 12 months (249)
No 874 132 (15.1) Reference
Yes 335 47 (14.0) 0.92 (0.64-1.31) .64
Unknown 249 33 (13.2) 0.86 (0.57-1.29) .47
Hospital length of stay, days (0)
0-2 377 43 (11.4) Reference
2.01-3 244 27 (11.1) 0.97 (0.58-1.61) .90
3.01-4.25 282 34 (12.1) 1.06 (0.66-1.72) .80
4.26-7 267 37 (13.9) 1.25 (0.78-2.00) .35
>7 288 71 (24.6) 2.54 (1.68-3.85) <.0001
Diagnoses and conditions
Charlson Comorbidity Index (0)
1-2 807 96 (11.9) Reference
3-5 558 97 (17.4) 1.56 (1.15-2.12) .0042
6-10 93 19 (20.4) 1.90 (1.10-3.29) .020
Organ system dysfunctions (0)
0 1229 180 (14.6) Reference
1 190 24 (12.6) 0.84 (0.53-1.33) .46
2-5 39 8 (20.5) 1.50 (0.68-3.32) .31
Atrial ﬁbrillation (0) 139 25 (18.0) 1.33 (0.84-2.10) .23
Coronary artery disease (0) 376 58 (15.4) 1.10 (0.79-1.53) .57
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Table IV. Continued.
Patient characteristics (No. missing) Patients, No.
Patients who were readmitted
No. (%) OR (95% CI) Pa
Cancer (0) 25 5 (20.0) 1.48 (0.55-3.99) .43
Chronic kidney disease (0) 216 40 (18.5) 1.41 (0.97-2.07) .072
Chronic obstructive lung disease (0) 260 39 (15.0) 1.05 (0.72-1.52) .82
Diabetes (0) 589 101 (17.2) 1.41 (1.05-1.89) .02
End-stage renal disease (0) 74 16 (21.6) 1.67 (0.94-2.97) .076
Fluid or electrolyte imbalance (0) 117 30 (25.6) 2.20 (1.41-3.42) .0004
Heart failure (0) 150 28 (18.7) 1.40 (0.90-2.18) .13
Pneumonia (0) 20 6 (30.0) 2.56 (0.97-6.75) .048
Sepsis (0) 15 5 (33.3) 2.99 (1.01-8.82) .038
Laboratory studiesd
Absolute lymphocyte count <800/mL (134) 301 52 (17.3) 1.30 (0.92-1.83) .13
AST >100 U/L (1035) 21 10 (47.6) 5.56 (2.33-13.2) <.0001
BNP >400 pg/mL (1371) 42 10 (23.8) 1.88 (0.91-3.88) .084
Blood urea nitrogen $35 mg/dL (86) 175 40 (22.9) 1.91 (1.30-2.82) .0009
eGFR <40 mL/min/1.73 m2 (81) 236 54 (22.9) 2.00 (1.41-2.83) <.0001
Hemoglobin (nadir) <8 g/dL (113) 122 31 (25.4) 2.17 (1.40-3.36) .0004
Platelet count <100,000/mL (165) 81 11 (13.6) 0.92 (0.48-1.77) .80
Serum
Creatinine $2 mg/dL (81) 148 36 (24.3) 2.07 (1.38-3.11) .0004
Albumin <3 g/dL (950) 255 57 (22.4) 1.95 (1.39-2.73) <.0001
Potassium >5.5 mmol/L (72) 54 13 (24.1) 1.92 (1.01-3.65) .043
Sodium (nadir) <130 mmol/L (92) 65 16 (24.6) 1.07 (0.67-1.69) .78
Total bilirubin >2 mg/dL (1041) 13 7 (46.1) 5.15 (1.72-15.5) .0012
Troponin I >0.2 mg/L (1338) 22 5 (22.7) 1.75 (0.64-4.78) .27
White blood cells >15,000/mL (136) 173 42 (24.3) 2.10 (1.43-3.08) .0001
Treatments and procedures
Beers criteria, any agent (age >74 years) (0) 118 20 (17.0) 1.36 (0.76-2.43) .30
>30 medications ordered and dispensed (0) 71 21 (29.6) 2.63 (1.54-1.48) .0002
SSRIs or SNRIs (0) 89 19 (21.4) 1.65 (0.97-2.81) .06
Procedures
Amputation (0) 82 22 (26.8) 2.29 (1.37-3.82) .0012
Blood transfusion (0) 146 27 (18.5) 1.38 (0.88-2.16) .15
Embolectomy (0) 36 8 (22.2) 1.71 (0.77-3.79) .19
Hemodialysis (0) 65 13 (20.0) 1.50 (0.80-2.81) .20
Thrombolysis (0) 46 11 (23.9) 1.89 (0.95-3.79) .067
AST, Aspartate aminotransferase; BNP, B-type natriuretic peptide; CI, conﬁdence interval; eGFR, estimated glomerular ﬁltration rate; OR, odds ratio; SNRI,
serotonin-norepinephrine reuptake inhibitor; SSRI, selective serotonin reuptake inhibitor.
ac2 test of the proportion of patients readmitted.
bTo protect conﬁdentiality, the age of patients >90 years was recoded to 90.
cIncludes patients aged $65 with other or unknown insurance.
dLaboratory tests that were not performed were considered normal.
JOURNAL OF VASCULAR SURGERY
Volume 58, Number 1 Vogel and Kruse 95remain unclear, but may be related to overall health or may
represent a complication after a vascular procedure.
Beyond comorbidities, we assessed disease severity with
respect to readmission after LE procedures and observed
that increased disease states trended toward signiﬁcance
with respect to predicting readmission. The highest read-
mission rates were in the ulceration and gangrene cohort,
with a 30-day readmission rate of 20% to 24%. This read-
mission rate has been corroborated from Medicare data
and tibioperoneal interventions.10 Patients with gangrene
as an indication for tibioperoneal angioplasty were 1.8
times as likely to be readmitted 30 days after discharge.10
Our analysis also demonstrated a higher-than-expected
readmission rate in population with claudication, with a 30-
day readmission rate of 10% to 11% in these healthier
patients. Previous evaluations using state data have
described increased procedure rates in claudicant patientseven though these patients were more often younger and
healthier.2 A subset analysis of the patients with a diagnosis
of claudication was evaluated looking at predictors for
readmission in this healthier population. As was found in
the entire population, African American patients and those
with a longer LOS were at higher risk of readmission. In
addition, increased readmission was associated with being
in a nonteaching hospital, having chronic kidney disease,
or having an elevated WBC count. This suggests that
among claudicant patients, the sicker patients with greater
comorbidities were readmitted. The reasons for greater
readmission among nonteaching hospitals are unclear
from this analysis but have been evaluated in other large
state data sets and were associated with different practice
patterns for use of endovascular technology.12
Hospital complications can also negatively inﬂuence
readmission.11 Medical complications that occur during
Table V. Results from generalized estimating equations
of 30-day hospital readmission among patients with
peripheral artery disease (PAD) who received lower
extremity procedures
Variable Coefﬁcient OR (95% CI) P
PAD severity
Unspeciﬁed/claudication . Reference .
Rest pain 0.2244 1.25 (0.79-1.99) .34
Ulcer or gangrene 0.3179 1.37 (0.99-1.92) .061
Male sex 0.3266 1.39 (0.97-1.98) .074
African American ethnicity 0.3305 1.39 (0.88-2.19) .15
Charlson Comorbidity
Index
0.1100 1.12 (1.00-1.25) .051
Length of staya 0.0449 1.25 (1.11-1.41) .0002
Aspartate aminotransferase
>100 U/L
1.0598 2.87 (1.52-5.48) .0012
>30 medications ordered
and dispensed
0.6075 1.84 (1.22-2.76) .0035
Endovascular procedure 0.2505 1.28 (0.96-1.73) .097
CI, Conﬁdence interval; OR, odds ratio.
aOR shown is for a 5-day change.
JOURNAL OF VASCULAR SURGERY
96 Vogel and Kruse July 2013the hospital stay after general surgery procedures have been
associated with increased LOS as well as increased readmis-
sion.11 This analysis found similar ﬁndings in the vascular
surgery population. The diagnosis of ﬂuid and electrolyte
imbalance was associated with increased readmission after
LE procedures, and these patients were 2.2-times as likely
to be readmitted within #30 days. This diagnosis includes
preventable conditions such as ﬂuid overload, hyperpotas-
semia, and hypopotassemia. Other studies have also
demonstrated that among patients who were rehospitalized
#30 days after a surgical discharge, up to 70.5% were reho-
spitalized for a medical condition.1
Other in-hospital complications that were predictive of
readmission after LE procedures were sepsis and infectious
complications. Patients with a diagnosis of sepsis were 2.99
times as likely to be readmitted. This ﬁnding was reinforced
with laboratory data suggestive of infectionwithWBCcounts
>15,000/mL. These patients were 2.10 times as likely to be
readmitted after LE procedures. Other studies have shown
that infectious complications after vascular surgery are signif-
icantly associated with increased health care resource use and
overall cost.13,14 As well, evaluation of general surgery proce-
dures using the National Surgical Quality Improvement
Project determined that surgical infection was one of the
most common reasons for readmission, at 22.1%, and it was
suggested thatminimizing these postoperative complications
would decrease postoperative readmissions.11
Another predictive factor identiﬁed from this analysis
for readmission was the association on LOS and the effect
on subsequent readmission that may represent complica-
tions. In the LE procedure population, a LOS of 4 to 7
days was associated with an OR of 1.25 as likely to be read-
mitted, and this increased to 2.54 times as likely if the
hospital LOS was >7 days. Authors of previous evaluations
of this phenomenon have suggested that LOS may be
a surrogate for hospital complications in the surgicalpopulation.15 Evaluating other surgical procedures,
Schneider et al16 evaluated risk factors associated with read-
mission among a nationwide cohort of patients after colo-
rectal surgery and concluded that factors associated with
increased risk of readmission included LOS, CCI scores,
and postoperative complications.
Regarding demographics, African Americans were 1.56
times as likely to be readmitted after LE procedures. Silver-
stein et al17 described that African American race predicted
30-day readmission in the Medicare population. Others
have found that black patients are more likely to be read-
mitted after hospitalization.10,18 After multivariable logistic
regression, men in our sample were 1.39 times as likely to
be readmitted as women. Other population-based studies
evaluating LE vascular procedures have suggested that
women with PAD are more likely to experience faster func-
tional decline than men and that sex disparities have existed
in the treatment of PAD.19,20
This analysis also evaluated the number of medications
that were ordered and dispensed during a hospitalization.
Multiple validated publications have demonstrated that poly-
pharmacy was associated with adverse health care in the
elderly and with readmission.21-23 This analysis using bivari-
able and multivariable logistic regression demonstrated
a signiﬁcant association between 30-day readmission and
>30 medications ordered and dispensed. Bivariate analysis
showed this cohort of patients was 2.63 times as likely to be
readmitted, and this remained signiﬁcant in ourmultivariable
logistic model. Dierich et al23 found that patients readmitted
to the hospital were older, sicker, more cognitively impaired,
and had complex medication regimens that included signiﬁ-
cant polypharmacy and inappropriate medication use. This
suggests that patients who received multiple medications or
were taking multiple medications after LE procedures were
more likely to be readmitted. Aswell,Martin et al24 evaluated
predictive factors of hospital readmission rates in patients
undergoing abdominal surgical procedures and found that
the number of discharge medications was associated with
increased readmission. A statistically signiﬁcant association
with readmission was found when >30 medications were
ordered and dispensed, even after controlling for comorbid-
ities and disease severity. Given the nature of our study
design, multiple medications were associated with readmis-
sion. It may be inferred that the vascular surgery population
is more likely older and has a higher likelihood of complex
medication regimens that may lead to readmission.
This study has an inherent limitation in that ICD-9-CM
codes were used to identify procedures, and coding can vary
between institutions. Component data undergo extensive
validity checks before they are added to Health Facts. We
were unable to determine when a procedure was performed
during the hospital stay, so it is possible that someprocedures
were emergencies although the admission was elective.
Furthermore, we were unable to determine when a proce-
dure was performed during the hospital stay, so patients
with both endovascular and open procedures in the same
index hospitalization were excluded. As well, there is a bias
in this study because all of the procedures were performed
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the data set. In addition, we are unable to determine read-
missions to hospitals in different health systems.
Because Cerner Corporations’ Health Facts is a propri-
etary database consisting of electronic clinical records from
hospitals and hospital systems that use Cerner’s electronic
health record, the ethnicity variable may not be completely
reﬂective of the United States population. Proportions by
ethnicity, however, are comparable to previously published
evaluations of LE procedures using Medicare data, which is
considered a representative sample of the elderly United
States population.10 As well, there is likely confounding
by indication because physicians may have offered sicker
patients endovascular procedures, although adjustment
was performed for comorbidities to minimize this bias.
CONCLUSIONS
This report is one of the ﬁrst to critically analyze readmis-
sion after elective LE procedures performed in a hospital-
based setting andassess granular data containedwithinCerner
Corporations’ Health Facts database. Endovascular proce-
dures, which are traditionally deemed less invasive, were not
associatedwith decreased readmission. In fact, aftermultivari-
able adjustment, endovascular procedures tended to be asso-
ciated with increased readmission (OR, 1.28; P ¼ .11). Risk
factors for readmission after surgery are numerous, and this
analysis has demonstrated that sepsis, male sex, a longer
hospital LOS, elevated liver enzymes, and increased medica-
tion usewere all associated with increased readmission. Silver-
stein et al17 has suggested that patients with a high risk of
30-day hospital readmission can be identiﬁed early in their
hospital course. Our analyses provide a ﬁrst step toward iden-
tifying vascular surgery patients at the highest risk of readmis-
sion so that preventive strategies can be developed.
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Supplementary Table I (online only). Bivariable association of selected factors with receipt of open or endovascular
lower extremity procedure for patients hospitalized with peripheral artery disease (PAD) (n ¼ 1458)
Patient characteristic (No. missing)
Patients,
No.
Patients who received endovascular procedures
No. (%) OR (95% CI) Pa
Demographic characteristics
Age, years (0)
18-49 78 36 (46.2) Reference
50-59 263 115 (43.7) 0.91 (0.55-1.51) .70
60-69 440 201 (45.7) 0.98 (0.61-1.59) .94
70-79 439 211 (48.1) 1.08 (0.67-1.75) .76
80-90b 238 118 (49.6) 1.15 (0.69-1.92) .60
Insurance (340)
Commercial, other 168 64 (38.1) Reference
Medicarec 844 422 (50.0) 1.62 (1.16-2.28) .005
Medicaid 56 26 (46.4) 1.41 (0.76-2.59) .27
Self-pay 50 17 (34.0) 0.84 (0.43-1.62) .60
Unknown 340 152 (44.7) 1.31 (0.90-1.92) .16
Marital status (271)
Married/life partner 614 292 (47.6) Reference
Divorced/separated 146 67 (45.9) 0.93 (0.65-1.34) .72
Single 187 87 (46.5) 0.96 (0.69-1.33) .80
Widowed 240 125 (52.1) 1.20 (0.89-1.62) .23
Unknown 271 110 (40.6) 0.75 (0.56-1.01) .055
Race/ethnicity (20)
African American 285 144 (50.3) 1.19 (0.92-1.55) .19
Caucasian 1129 521 (46.2) Reference
Other known/unknown 44 16 (36.4) 0.67 (0.36-1.25) .20
Sex (4)
Female 610 333 (54.6) 1.73 (1.40-2.13) <.0001
Male 848 348 (41.0) Reference
Hospital characteristics
Hospital bed size category (0)
<200 130 82 (63.1) Reference
200-299 297 183 (63.1) 0.94 (0.61-1.44) .77
300-499 322 156 (48.4) 0.55 (0.36-0.84) .005
>500 709 260 (36.7) 0.34 (0.23-0.50) <.0001
Teaching status (0)
Teaching 1035 435 (42.0) Reference
Nonteaching 423 246 (58.2) 1.92 (1.52-2.41) <.0001
Admission source (99)
Hospital, other facility 27 17 (63.0) 2.12 (0.96-4.66) .057
Skilled nursing facility, nursing home 10 5 (50.0) 1.24 (0.36-4.32) .73
Other 1322 589 (44.6) Reference
Unknown 99 70 (70.7) 3.00 (1.92-4.69) <.0001
Health care utilization
Hospital exposure prior 12 months (249)
No 874 376 (43.0) Reference
Yes 335 150 (44.8) 1.07 (0.83-1.38) .58
Unknown 249 155 (62.2) 2.18 (1.64-2.92) <.0001
Hospital length of stay, days (0)
0-2 377 308 (81.7) Reference
2.01-3 244 108 (44.3) 0.18 (0.12-0.26) <.0001
3.01-4.25 282 77 (27.3) 0.084 (0.058-0.12) <.0001
4.26-7 267 70 (26.2) 0.080 (0.055-0.12) <.0001
Over 7 288 118 (41.0) 0.16 (0.11-0.22) <.0001
Diagnoses and conditions
Charlson Comorbidity Index (0)
1-2 807 381 (47.2) Reference
3-5 558 251 (45.0) 0.91 (0.74-1.14) .42
6-10 93 49 (52.7) 1.25 (0.81-1.91) .32
Organ system dysfunctions (0)
0 1229 598 (48.7) Reference
1 190 74 (39.0) 0.67 (0.49-0.92) .013
2-5 39 9 (23.1) 0.32 (0.15-0.67) .002
Atrial ﬁbrillation (0) 139 78 (56.1) 1.52 (1.07-2.16) .019
Coronary artery disease (0) 376 174 (46.3) 0.98 (0.77-1.24) .85
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Patient characteristic (No. missing)
Patients,
No.
Patients who received endovascular procedures
No. (%) OR (95% CI) Pa
Cancer (0) 25 9 (36.0) 0.64 (0.28-1.45) .28
Chronic kidney disease (0) 216 131 (60.6) 1.94 (1.44-2.60) <.0001
Chronic obstructive lung disease (0) 260 106 (40.8) 0.75 (0.57-0.98) .034
Diabetes (0) 589 290 (49.2) 1.19 (0.96-1.46) .11
End-stage renal disease (0) 74 53 (71.6) 3.04 (1.81-5.09) <.0001
Fluid or electrolyte imbalance (0) 117 50 (47.0) 0.84 (0.57-1.23) .37
Heart failure (0) 150 86 (57.3) 1.61 (1.14-2.27) .006
Pneumonia (0) 20 10 (50.0) 1.14 (0.47-2.76) .77
Sepsis (0) 15 10 (66.7) 2.30 (0.78-6.77) .12
Laboratory studiesd
Absolute lymphocyte count <800/mL (134) 301 101 (33.6) 0.50 (0.39-0.66) <.0001
AST >100 U/L (1035) 21 6 (28.6) 0.45 (0.17-1.17) .093
BNP > 400 pg/mL (1371) 42 26 (61.9) 1.89 (1.00-3.55) .045
Blood urea nitrogen > 35 mg/dL (86) 175 99 (56.6) 1.57 (1.14-2.16) .005
eGFR <40 mL/min/1.73m2 (81) 236 129 (54.7) 1.46 (1.10-1.94) .008
Hemoglobin (nadir) <8 g/dL (113) 122 51 (41.8) 0.80 (0.55-1.17) .26
Platelet count <100,000/mL (165) 81 27 (33.3) 0.55 (0.34-0.89) .013
Serum
Creatinine $2 mg/dL (81) 148 86 (58.1) 1.67 (1.18-2.35) .003
Albumin <3 g/dL (950) 255 118 (46.3) 0.98 (0.75-1.28) .88
Potassium >5.5 mmol/L (72) 54 24 (44.4) 0.91 (0.53-1.57) .73
Sodium (nadir) <130 mmol/L (92) 65 18 (27.7) 0.42 (0.24-0.73) .002
Total bilirubin >2 mg/dL (1041) 13 3 (23.1) 0.34 (0.09-1.24) .086
Troponin I >0.2 mg/L (1338) 22 11 (50.0) 1.14 (0.49-2.65) .76
White blood cells >15,000/mL (136) 173 64 (37.0) 0.64 (0.46-0.88) .006
Treatments and procedures
Beers criteria, any agent (age >74) (0) 118 64 (54.2) 1.26 (0.83-1.93) .28
>30 medications ordered and dispensed (0) 71 22 (31.0) 0.50 (0.30-0.83) .0065
SSRI or SNRI (0) 89 41 (46.1) 0.97 (0.63-1.50) .90
Procedures
Amputation (0) 82 42 (51.2) 1.21 (0.78-1.89) .40
Blood transfusion (0) 146 46 (31.5) 0.49 (0.34-0.71) .0001
Embolectomy (0) 36 0 (0.0) Not computed <.0001
Hemodialysis (0) 65 47 (72.3) 3.13 (1.80-5.44) <.0001
Thrombolysis (0) 46 41 (89.1) 9.89 (3.88-25.2) <.0001
AST, Aspartate aminotransferase; BNP, B-type natriuretic peptide; CI, conﬁdence interval; eGFR, estimated glomerular ﬁltration rate; OR, odds ratio; SNRI,
serotonin-norepinephrine reuptake inhibitor; SSRI, selective serotonin reuptake inhibitor.
ac2 test of the proportion of patients who received endovascular vs open procedures.
bTo protect conﬁdentiality, the age of patients >90 years old was recoded to 90.
cIncludes patients age $65 with other or unknown insurance.
dLaboratory values that were not performed were considered normal.
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Supplementary Table II (online only). Comparison of the association of selected factors with readmission after receipt of
open or endovascular lower extremity procedure for patients hospitalized with peripheral artery disease (PAD) (n ¼ 1458)
Patient characteristic (No. missing)
Endovascular procedure Open procedure
OR (95% CI) Pa OR (95% CI) Pa
Demographic characteristics
Age, years (0)
18-49 Reference Reference
50-59 0.99 (0.36-2.70) .98 0.73 (0.27-1.99) .53
60-69 0.84 (0.32-2.20) .73 1.00 (0.39-2.54) .99
70-79 1.13 (0.44-2.91) .79 1.09 (0.43-2.78) .86
80-90b 0.51 (0.18-1.50) .22 0.99 (0.36-2.71) .98
Insurance (340)
Commercial, other Reference Reference
Medicarec 0.69 (0.35-1.34) .27 1.27 (0.67-2.41) .46
Medicaid 0.51 (0.13-1.97) .32 0.50 (0.11-2.35) .37
Self-pay 0.24 (0.030-2.02) .16 0.70 (0.19-2.62) .60
Unknown 0.73 (0.35-1.56) .42 1.07 (0.52-2.20) .85
Marital status (271)
Married/life partner Reference Reference
Divorced/separated 1.14 (0.58-2.24) .71 0.63 (0.28-1.38) .25
Single 0.68 (0.34-1.38) .29 0.98 (0.52-1.84) .96
Widowed 0.60 (0.32-1.12) .11 0.97 (0.53-1.76) .91
Unknown 0.75 (0.40-1.39) .36 0.75 (0.42-1.31) .31
Race/ethnicity (20)
African American 1.41 (0.88-2.28) .16 1.71 (1.06-2.76) .027
Caucasian Reference Reference
Other known/unknown Not calculated .10 0.83 (0.24-2.81) .76
Sex (4)
Female 0.70 (0.46-1.06) .094 0.93 (0.61-1.43) .74
Male Reference Reference
Hospital characteristics
Hospital bed size category (0)
<200 Reference Reference
200-299 0.91 (0.45-1.84) .80 2.27 (0.63-8.25) .20
300-499 0.59 (0.28-1.28) .18 2.41 (0.69-8.41) .16
500 or more 0.99 (0.51-1.91) .97 2.63 (0.79-8.71) .10
Teaching status (0)
Teaching Reference Reference
Not teaching 1.07 (0.70-1.65) .75 0.55 (0.31 - .96) .033
Admission source (99)
Hospital, other facility 2.50 (0.86-7.29) .082 1.51 (0.32-7.22) .60
Skilled nursing facility, nursing home 1.50 (0.17-13.6) .72 4.03 (0.67-24.4) .10
Other Reference Reference
Unknown 1.50 (0.80-2.82) .20 Not calculated
Health care utilization
Hospital exposure prior 12 months (249)
No Reference Reference
Yes 0.72 (0.42-1.24) .24 1.12 (0.69-1.81) .65
Unknown 0.62 (0.35-1.08) .088 1.24 (0.68-2.29) .48
Hospital length of stay (0)
0-2 days Reference Reference
2.01-3 days 1.37 (0.74-2.55) .32 0.83 (0.29-2.40) .73
3.01-4.25 days 1.22 (0.59-2.52) .59 1.33 (0.52-3.41) .56
4.26-7 days 1.37 (0.66-2.83) .40 1.60 (0.63-4.06) .32
Over 7 days 2.28 (1.32-3.93) .003 3.56 (1.44-8.80) .004
Diagnoses and conditions
Charlson Comorbidity Index (0)
1-2 Reference Reference
3-5 1.48 (0.95-2.30) .08 1.64 (1.07-2.52) .021
6-10 1.74 (0.82-3.70) .15 2.07 (0.94-4.58) .066
Organ system dysfunctions (0)
0 Reference Reference
1 0.64 (0.30-1.38) .25 1.03 (0.58-1.83) .93
2-5 0.66 (0.082-5.35) .70 1.96 (0.81-4.70) .13
Atrial ﬁbrillation (0) 1.51 (0.83-2.74) .17 1.08 (0.52-2.26) .84
Coronary artery disease (0) 0.97 (0.60-1.56) .89 1.24 (0.79-1.93) .35
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Patient characteristic (No. missing)
Endovascular procedure Open procedure
OR (95% CI) Pa OR (95% CI) Pa
Cancer (0) 1.60 (0.33-7.79) .56 1.44 (0.40-5.15) .57
Chronic kidney disease (0) 1.15 (0.69-1.92) .59 1.78 (1.02-3.16) .04
Chronic obstructive lung disease (0) 0.90 (0.50-1.63) .73 1.18 (0.72-1.94) .50
Diabetes (0) 1.42 (0.94-2.16) .10 1.39 (0.92-2.10) .11
End-stage renal disease (0) 1.71 (0.86-3.37) .12 1.48 (0.49-4.47) .49
Fluid or electrolyte imbalance (0) 1.85 (0.93-3.67) .075 2.53 (1.41-4.54) .001
Heart failure (0) 1.09 (0.59-2.02) .78 1.84 (0.98-3.47) .054
Pneumonia (0) 3.81 (1.06-13.7) .028 1.56 (0.33-7.44) .57
Sepsis (0) 1.39 (0.29-6.66) .68 9.53 (1.57-57.7) .003
Laboratory studiesd
Absolute lymphocyte count <800/mL (134) 1.46 (0.85-2.51) .17 1.26 (0.80-1.97) .32
AST >100 U/L (1035) 2.81 (0.51-15.5) .22 7.57 (2.68-21.3) <.0001
BNP >400 pg/mL (1371) 2.59 (1.09-6.12) .025 0.88 (0.20-3.94) .87
Blood urea nitrogen >35 mg/dL (86) 2.01 (1.20-3.37) .007 1.76 (0.98-3.20) .058
eGFR <40 mL/min/1.73m2 (81) 1.96 (1.22-3.15) .005 2.02 (1.21-3.35) .006
Hemoglobin (nadir) <8 g/dL (113) 1.59 (0.79-3.21) .19 2.75 (1.57-4.84) .0003
Platelet count <100,000/mL (165) 0.43 (0.10-1.86) .25 1.26 (0.60-2.66) .54
Serum
Creatinine $2 mg/dL (81) 1.84 91.06-3.20) .028 2.36 (1.28-4.33) .005
Albumin <3 g/dL (950) 1.65 (1.00-2.72) .05 2.26 (1.42-3.59) .0004
Potassium >5.5 mmol/L (72) 2.38 (0.96-5.88) .054 1.58 (0.63-3.96) .32
Sodium (nadir) <130 mmol/L (92) 0.69 (0.16-3.04) .62 2.87 (1.48-5.56) .0012
Total bilirubin >2 mg/dL (1041) 11.3 (1.01-126) .013 4.25 (1.18-15.3) .016
Troponin I >0.2 mg/L (1338) 0.55 (0.070-4.35) .57 3.64 (1.05-12.6) .03
White blood cells >15,000/mL (136) 1.64 (0.87-3.09) .12 2.54 (1.56-4.14) .0001
Treatments and procedures
Beers criteria, any agent (age >74) (0) 1.34 (0.58-3.06) .49 1.41 (0.62-3.19) .40
>30 medications ordered and dispensed (0) 2.70 (1.07-6.80) .028 2.70 (1.40-5.20) .002
SSRI or SNRI (0) 1.37 (0.61-3.06) .44 1.94 (0.96-3.92) .062
Procedures
Amputation (0) 1.56 (0.72-3.37) .25 3.25 (1.62-6.53) .0005
Blood transfusion (0) 1.00 (0.43-2.29) .99 1.67 (0.98-2.87) .059
Embolectomy (0) None received 1.83 (0.81-4.13) .14
Hemodialysis (0) 1.34 (0.63-2.87) .44 1.80 (0.58-5.57) .30
Thrombolysis (0) 1.37 (0.62-3.06) .44 9.53 (1.57-57.7) .003
AST, Aspartate aminotransferase; BNP, B-type natriuretic peptide; CI, conﬁdence interval; eGFR, estimated glomerular ﬁltration rate; OR, odds ratio; SNRI,
serotonin-norepinephrine reuptake inhibitor; SSRI, selective serotonin reuptake inhibitor.
ac2 test of the proportion of patients readmitted who received either endovascular or open procedures.
bTo protect conﬁdentiality, the age of patients >90 years was recoded to 90.
cIncludes patients age $65 with other or unknown insurance.
dLaboratory tests that were not performed were considered normal.
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